BMT CTN 2203
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Near Add Your Location
Sorting 20 by
Center of Excellence
- Accepting patients
- Show Principal Investigator
Center of Excellence
Stanford University Cancer Institute (Palo Alto)
Stanford, CA
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Blood and Marrow Transplant Group of Georgia
Atlanta, GA
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
Center of Excellence
Massachusetts General Hospital
Boston, MA
- Accepting patients
- Accepting patients
Center of Excellence
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.